论文信息 - LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial - 字舞流文

LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial

P. Laurent-Puig | C. Lepage | C. Borg | B. Buecher | J. Taieb | F. Di Fioré | D. Tougeron | F. El Hajbi | V. Randrian | E. Barbier | L. Evesque | H. Perrier | J. Bez | C. Gallois | S. Corbinais | C. Toullec | O. Bouché | T. André | F. El hajbi | F. El Hajbi